Trial intelligence / Profile preview

Alternative hepatitis B vaccination schedules in a poor population in Aparecida de Goiânia

RBR-5cc28frPhase 2Completed

Sponsor
Faculdade de Enfermagem da Universidade Federal de Goiás
Start
Aug 2019
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of hepatitis b vaccine (recombinant) in hepatitis B (HBV), sponsored by Faculdade de Enfermagem da Universidade Federal de Goiás. Started Aug 2019; status: completed.

02

Drugs

hepatitis b vaccine (recombinant)
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on RBR-5cc28fr.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-5cc28fr.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call